Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2025-12-31 @ 5:56 PM
Study NCT ID:
NCT04927858
Status:
COMPLETED
Last Update Posted:
2021-07-22
First Post:
2021-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-10
First Submit QC Date:
None
Study First Post Date:
2021-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-16
Results First Submit QC Date:
None
Results First Post Date:
2021-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-21
Last Update Post Date:
2021-07-22
Last Update Post Date Type:
ACTUAL